Male condom sales in the United States increased 23.4 percent to $37 million during the four weeks ending April 18 from the same period last year.
The figure still represents a 4.4 percent drop in all of 2020.
The condom maker attributed recent growth to relaxed social distancing rules, with CEO Laxman Narasimhan revealing that they saw improved sales in markets where social restrictions are being eased.
Condom sales plummeted during the pandemic as people stayed at home. But as more are getting vaccinated and Covid-19 safety restrictions are loosening, condom sales went up.
Durex sales still grew last year, despite a challenging first half of 2020 and flat sales in 2019.
Britta Bomhard, chief marketing officer of Church & Dwight (CHD), the maker of Trojan condoms, noted that 18-to 24-year-olds can't wait to get their social lives back.
Condoms sales, says CHD CEO Matt Farrell, are expected to grow on-year as society opens up and consumers become more mobile.
Even before the pandemic, condom sales dropped 2.4 percent in 2017 and 3.4 percent in 2018 before climbing 1.2 percent in 2019.
Kevin Grundy, a consumer goods analyst at Jefferies, attributed condoms' lower market share in recent years to competition posed by other forms of contraception, including women's morning-after pill.
Researchers from Indiana University and Sweden's Karolinska Institutet attributed young Americans having less sex to a variety of factors, including delayed adulthood and the rise of technology and social media.
Men who were unemployed, had part-time employment or lower incomes were more likely to be sexually inactive, researchers found.


Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
REPAY Stock Rises After Visa Platform Connect Collaboration
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Alphabet Shifts AI Strategy Toward Commercial Growth, Goldman Sachs Says
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 



